Engineering a CD4 mimetic inhibiting the binding of the human immunodeficiency virus-1 (HIV-1) envelope glycoprotein gp120 to human lymphocyte CD4 by the transfer of a CD4 functional site to a small natural scaffold

被引：16
|
作者：
Drakopoulou, E [1 ]
Vizzavona, J [1 ]
Vita, C [1 ]
机构：
[1] CEA, Dept Ingn & Etud Prot, CE Saclay, F-91190 Gif Sur Yvette, France
来源：
LETTERS IN PEPTIDE SCIENCE | 1998年 / 5卷 / 2-3期
关键词：
active site transfer; chimeric mini-protein; drug lead; HIV inhibitor;
D O I：
10.1023/A:1008837427367
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
The solvent-exposed CDR2-like region of human CD4 was transferred to the structural scaffold of scorpion charybdotoxin, as a means to reproduce that site in a native-like conformation. The chimeric mini-protein (33 amino acids long), obtained by solid-phase synthesis, is able to specifically prevent the interaction of HIV-1 gp120 with CD4. This CD4 mimetic may represent a valuable tool in the study of the HIV-cell interactions and as a lead in the development of antiviral drugs.
引用
下载
收藏
页码：241 / 245
页数：5
相关论文
共 50 条
  • [21] Induction of CD4(+) T cell depletion in mice doubly transgenic for HIV gp120 and human CD4
    Finco, O
    Nuti, S
    DeMagistris, MT
    Mangiavacchi, L
    Aiuti, A
    Forte, P
    Fantoni, A
    vanderPutten, H
    Abrignani, S
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1997, 27 (06) : 1319 - 1324
  • [22] ANTIBODIES AGAINST CD4 PEPTIDES BLOCK BINDING OF GP120 TO NATIVE CD4
    CARTER, JM
    KATZHENDLER, J
    WASSEF, N
    ALVING, C
    DOCTOR, BP
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1993, : 60 - 60
  • [23] Use of human CD4 transgenic mice for studying immunogenicity of HIV-1 envelope protein gp120
    Seagal, J
    Spectorman, E
    Gershoni, JM
    Denisova, GF
    TRANSGENIC RESEARCH, 2001, 10 (02) : 113 - 120
  • [24] Use of Human CD4 Transgenic Mice for Studying Immunogenicity of HIV-1 Envelope Protein gp120
    J. Seagal
    E. Spectorman
    J.M. Gershoni
    G.F. Denisova
    Transgenic Research, 2001, 10 : 113 - 120
  • [25] SYNTHETIC CD4 PEPTIDE (81-92) DERIVATIVES INHIBIT THE INTERACTION OF HIV-1 GP120 WITH CD4
    KALYANARAMAN, VS
    OSBORNE, J
    RUSCHE, D
    EIDEN, L
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1990, 6 (01) : 119 - 119
  • [26] CONSTRUCTION OF A BINDING-SITE FOR HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GP120 IN RAT CD4
    SCHOCKMEL, GA
    SOMOZA, C
    DAVIS, SJ
    WILLIAMS, AF
    HEALEY, D
    JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 175 (01): : 301 - 304
  • [27] EFFECTS OF CD4 PERTURBATION BY HIV-1 GP120 ON CD3 AND CD4 CYTOSKELETAL ASSOCIATION AND INDUCED MIGRATION IN HUMAN LYMPHOCYTES-T
    THEODORE, AC
    CRUIKSHANK, WW
    CLINICAL RESEARCH, 1991, 39 (02): : A381 - A381
  • [28] BINDING OF SOLUBLE CD4 TO GP120 PROMOTES BINDING OF HIV-1 VIRIONS TO CD4-NEGATIVE CELLS
    DEMARIA, S
    BUSHKIN, Y
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1995, : 218 - 218
  • [29] Human immunodeficiency virus type 1 attachment to HeLa CD4 cells is CD4 independent and gp120 dependent and requires cell surface heparans
    Mondor, I
    Ugolini, S
    Sattentau, QJ
    JOURNAL OF VIROLOGY, 1998, 72 (05) : 3623 - 3634
  • [30] OLIGOSACCHARIDE-MEDIATED INTERACTIONS OF THE ENVELOPE GLYCOPROTEIN GP120 OF HIV-1 THAT ARE INDEPENDENT OF CD4 RECOGNITION
    LARKIN, M
    CHILDS, RA
    MATTHEWS, TJ
    THIEL, S
    MIZUOCHI, T
    LAWSON, AM
    SAVILL, JS
    HASLETT, C
    DIAZ, R
    FEIZI, T
    AIDS, 1989, 3 (12) : 793 - 798
12345